Advertisement

Topics

Genkyotex starts enrolment in Phase II trial of GKT831 to treat PBC

19:00 EDT 28 Jun 2017 | Net Resources International

French company Genkyotex has started patient enrolment in a Phase II clinical trial of GKT831 for the treatment of patients with primary biliary cholangitis (PBC).

Original Article: Genkyotex starts enrolment in Phase II trial of GKT831 to treat PBC

NEXT ARTICLE

More From BioPortfolio on "Genkyotex starts enrolment in Phase II trial of GKT831 to treat PBC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...